nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—esophageal cancer	0.42	1	CiPCiCtD
Gemcitabine—pancreatic cancer—esophageal cancer	0.143	0.553	CtDrD
Gemcitabine—lung cancer—esophageal cancer	0.115	0.447	CtDrD
Gemcitabine—CDA—Capecitabine—esophageal cancer	0.114	0.575	CbGbCtD
Gemcitabine—TYMS—Capecitabine—esophageal cancer	0.0506	0.256	CbGbCtD
Gemcitabine—ABCB1—esophageal cancer	0.041	1	CbGaD
Gemcitabine—TYMS—Methotrexate—esophageal cancer	0.0166	0.0837	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—esophageal cancer	0.0137	0.069	CbGbCtD
Gemcitabine—RRM1—larynx—esophageal cancer	0.00196	0.0999	CbGeAlD
Gemcitabine—ABCB1—Cisplatin—esophageal cancer	0.00196	0.0099	CbGbCtD
Gemcitabine—POLD1—exocrine gland—esophageal cancer	0.00159	0.081	CbGeAlD
Gemcitabine—ABCB1—Methotrexate—esophageal cancer	0.00127	0.00643	CbGbCtD
Gemcitabine—POLD1—neck—esophageal cancer	0.00102	0.0518	CbGeAlD
Gemcitabine—SLC28A1—digestive system—esophageal cancer	0.00079	0.0402	CbGeAlD
Gemcitabine—SLC28A3—trachea—esophageal cancer	0.000561	0.0286	CbGeAlD
Gemcitabine—CMPK1—bronchus—esophageal cancer	0.000544	0.0277	CbGeAlD
Gemcitabine—CMPK1—smooth muscle tissue—esophageal cancer	0.000532	0.0271	CbGeAlD
Gemcitabine—POLD1—digestive system—esophageal cancer	0.000526	0.0268	CbGeAlD
Gemcitabine—SLC28A3—digestive system—esophageal cancer	0.000483	0.0246	CbGeAlD
Gemcitabine—POLE—trachea—esophageal cancer	0.000457	0.0233	CbGeAlD
Gemcitabine—POLD1—lung—esophageal cancer	0.00044	0.0224	CbGeAlD
Gemcitabine—CMPK1—digestive system—esophageal cancer	0.00042	0.0214	CbGeAlD
Gemcitabine—RRM2—bronchus—esophageal cancer	0.00042	0.0214	CbGeAlD
Gemcitabine—SLC28A3—lung—esophageal cancer	0.000403	0.0205	CbGeAlD
Gemcitabine—POLE—digestive system—esophageal cancer	0.000394	0.02	CbGeAlD
Gemcitabine—CMPK1—lung—esophageal cancer	0.000351	0.0179	CbGeAlD
Gemcitabine—RRM1—bronchus—esophageal cancer	0.000349	0.0177	CbGeAlD
Gemcitabine—RRM1—smooth muscle tissue—esophageal cancer	0.000341	0.0174	CbGeAlD
Gemcitabine—POLE—lung—esophageal cancer	0.000329	0.0167	CbGeAlD
Gemcitabine—RRM2—digestive system—esophageal cancer	0.000324	0.0165	CbGeAlD
Gemcitabine—TYMS—bronchus—esophageal cancer	0.000316	0.0161	CbGeAlD
Gemcitabine—TYMS—smooth muscle tissue—esophageal cancer	0.000309	0.0157	CbGeAlD
Gemcitabine—POLD1—lymph node—esophageal cancer	0.000301	0.0153	CbGeAlD
Gemcitabine—SLC29A1—bronchus—esophageal cancer	0.000283	0.0144	CbGeAlD
Gemcitabine—POLA1—lung—esophageal cancer	0.000283	0.0144	CbGeAlD
Gemcitabine—DCK—bronchus—esophageal cancer	0.000271	0.0138	CbGeAlD
Gemcitabine—RRM2—lung—esophageal cancer	0.000271	0.0138	CbGeAlD
Gemcitabine—CDA—lymph node—esophageal cancer	0.00027	0.0137	CbGeAlD
Gemcitabine—RRM1—digestive system—esophageal cancer	0.000269	0.0137	CbGeAlD
Gemcitabine—ABCC10—bronchus—esophageal cancer	0.000258	0.0131	CbGeAlD
Gemcitabine—SLC29A1—trachea—esophageal cancer	0.000254	0.013	CbGeAlD
Gemcitabine—SLC29A2—lymph node—esophageal cancer	0.000252	0.0128	CbGeAlD
Gemcitabine—TYMS—digestive system—esophageal cancer	0.000244	0.0124	CbGeAlD
Gemcitabine—DCK—trachea—esophageal cancer	0.000243	0.0124	CbGeAlD
Gemcitabine—CMPK1—lymph node—esophageal cancer	0.00024	0.0122	CbGeAlD
Gemcitabine—ABCC10—trachea—esophageal cancer	0.000232	0.0118	CbGeAlD
Gemcitabine—RRM1—lung—esophageal cancer	0.000225	0.0114	CbGeAlD
Gemcitabine—POLE—lymph node—esophageal cancer	0.000225	0.0114	CbGeAlD
Gemcitabine—SLC29A1—digestive system—esophageal cancer	0.000219	0.0111	CbGeAlD
Gemcitabine—DCK—digestive system—esophageal cancer	0.000209	0.0106	CbGeAlD
Gemcitabine—TYMS—lung—esophageal cancer	0.000204	0.0104	CbGeAlD
Gemcitabine—ABCC10—digestive system—esophageal cancer	0.000199	0.0101	CbGeAlD
Gemcitabine—POLA1—lymph node—esophageal cancer	0.000194	0.00986	CbGeAlD
Gemcitabine—RRM2—lymph node—esophageal cancer	0.000185	0.00942	CbGeAlD
Gemcitabine—SLC29A1—lung—esophageal cancer	0.000183	0.00931	CbGeAlD
Gemcitabine—DCK—lung—esophageal cancer	0.000175	0.00889	CbGeAlD
Gemcitabine—ABCC10—lung—esophageal cancer	0.000166	0.00847	CbGeAlD
Gemcitabine—Hearing impaired—Cisplatin—esophageal cancer	0.000165	0.00534	CcSEcCtD
Gemcitabine—Pain—Carboplatin—esophageal cancer	0.000164	0.00529	CcSEcCtD
Gemcitabine—Lamivudine—ABCC2—esophageal cancer	0.000163	0.731	CrCbGaD
Gemcitabine—RRM1—lymph node—esophageal cancer	0.000154	0.00783	CbGeAlD
Gemcitabine—Pleural effusion—Capecitabine—esophageal cancer	0.000151	0.00489	CcSEcCtD
Gemcitabine—Body temperature increased—Carboplatin—esophageal cancer	0.000151	0.00489	CcSEcCtD
Gemcitabine—Skin exfoliation—Cisplatin—esophageal cancer	0.00015	0.00485	CcSEcCtD
Gemcitabine—Hepatotoxicity—Capecitabine—esophageal cancer	0.00015	0.00485	CcSEcCtD
Gemcitabine—Fluid retention—Cisplatin—esophageal cancer	0.000149	0.00483	CcSEcCtD
Gemcitabine—Neuropathy—Cisplatin—esophageal cancer	0.000148	0.00477	CcSEcCtD
Gemcitabine—Febrile neutropenia—Methotrexate—esophageal cancer	0.000143	0.00464	CcSEcCtD
Gemcitabine—Petechiae—Capecitabine—esophageal cancer	0.000141	0.00455	CcSEcCtD
Gemcitabine—Eruption—Methotrexate—esophageal cancer	0.00014	0.00453	CcSEcCtD
Gemcitabine—TYMS—lymph node—esophageal cancer	0.000139	0.0071	CbGeAlD
Gemcitabine—Hypoxia—Methotrexate—esophageal cancer	0.000136	0.00439	CcSEcCtD
Gemcitabine—Proteinuria—Capecitabine—esophageal cancer	0.000132	0.00426	CcSEcCtD
Gemcitabine—Protein urine present—Capecitabine—esophageal cancer	0.00013	0.00421	CcSEcCtD
Gemcitabine—Deafness—Cisplatin—esophageal cancer	0.000128	0.00412	CcSEcCtD
Gemcitabine—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000127	0.00412	CcSEcCtD
Gemcitabine—Cellulitis—Capecitabine—esophageal cancer	0.000127	0.00412	CcSEcCtD
Gemcitabine—Hypocalcaemia—Capecitabine—esophageal cancer	0.000127	0.00409	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000126	0.00407	CcSEcCtD
Gemcitabine—SLC29A1—lymph node—esophageal cancer	0.000125	0.00637	CbGeAlD
Gemcitabine—Ulcer—Capecitabine—esophageal cancer	0.000123	0.00396	CcSEcCtD
Gemcitabine—Blood bilirubin increased—Capecitabine—esophageal cancer	0.000123	0.00396	CcSEcCtD
Gemcitabine—Interstitial lung disease—Methotrexate—esophageal cancer	0.000122	0.00394	CcSEcCtD
Gemcitabine—Hearing impaired—Capecitabine—esophageal cancer	0.000122	0.00394	CcSEcCtD
Gemcitabine—Bone pain—Capecitabine—esophageal cancer	0.000121	0.00391	CcSEcCtD
Gemcitabine—DCK—lymph node—esophageal cancer	0.000119	0.00608	CbGeAlD
Gemcitabine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000118	0.00381	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000116	0.00377	CcSEcCtD
Gemcitabine—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.000116	0.00375	CcSEcCtD
Gemcitabine—Injection site reaction—Capecitabine—esophageal cancer	0.000115	0.00372	CcSEcCtD
Gemcitabine—ABCC10—lymph node—esophageal cancer	0.000114	0.00579	CbGeAlD
Gemcitabine—Pleural effusion—Methotrexate—esophageal cancer	0.000113	0.00364	CcSEcCtD
Gemcitabine—Influenza like illness—Capecitabine—esophageal cancer	0.000113	0.00364	CcSEcCtD
Gemcitabine—Hepatotoxicity—Methotrexate—esophageal cancer	0.000112	0.00361	CcSEcCtD
Gemcitabine—Skin exfoliation—Capecitabine—esophageal cancer	0.000111	0.00358	CcSEcCtD
Gemcitabine—Face oedema—Cisplatin—esophageal cancer	0.00011	0.00356	CcSEcCtD
Gemcitabine—Fluid retention—Capecitabine—esophageal cancer	0.00011	0.00356	CcSEcCtD
Gemcitabine—Neuropathy—Capecitabine—esophageal cancer	0.000109	0.00352	CcSEcCtD
Gemcitabine—Blood creatinine increased—Cisplatin—esophageal cancer	0.000107	0.00346	CcSEcCtD
Gemcitabine—Petechiae—Methotrexate—esophageal cancer	0.000105	0.00339	CcSEcCtD
Gemcitabine—Hypokalaemia—Cisplatin—esophageal cancer	0.000104	0.00336	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000103	0.00332	CcSEcCtD
Gemcitabine—Sepsis—Capecitabine—esophageal cancer	0.000101	0.00325	CcSEcCtD
Gemcitabine—Extravasation—Methotrexate—esophageal cancer	9.89e-05	0.0032	CcSEcCtD
Gemcitabine—Proteinuria—Methotrexate—esophageal cancer	9.82e-05	0.00317	CcSEcCtD
Gemcitabine—Protein urine present—Methotrexate—esophageal cancer	9.68e-05	0.00313	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	9.67e-05	0.00313	CcSEcCtD
Gemcitabine—Hepatic function abnormal—Capecitabine—esophageal cancer	9.63e-05	0.00311	CcSEcCtD
Gemcitabine—Bone disorder—Methotrexate—esophageal cancer	9.55e-05	0.00309	CcSEcCtD
Gemcitabine—Hyperbilirubinaemia—Methotrexate—esophageal cancer	9.49e-05	0.00307	CcSEcCtD
Gemcitabine—Deafness—Capecitabine—esophageal cancer	9.4e-05	0.00304	CcSEcCtD
Gemcitabine—Pancytopenia—Cisplatin—esophageal cancer	9.37e-05	0.00303	CcSEcCtD
Gemcitabine—Hepatic failure—Capecitabine—esophageal cancer	9.36e-05	0.00303	CcSEcCtD
Gemcitabine—Hepatic enzyme increased—Methotrexate—esophageal cancer	9.12e-05	0.00295	CcSEcCtD
Gemcitabine—Ulcer—Methotrexate—esophageal cancer	9.12e-05	0.00295	CcSEcCtD
Gemcitabine—Renal impairment—Capecitabine—esophageal cancer	8.84e-05	0.00286	CcSEcCtD
Gemcitabine—Vasculitis—Methotrexate—esophageal cancer	8.84e-05	0.00286	CcSEcCtD
Gemcitabine—Dermatitis bullous—Capecitabine—esophageal cancer	8.8e-05	0.00285	CcSEcCtD
Gemcitabine—Respiratory failure—Methotrexate—esophageal cancer	8.79e-05	0.00284	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Cisplatin—esophageal cancer	8.67e-05	0.0028	CcSEcCtD
Gemcitabine—Renal failure—Cisplatin—esophageal cancer	8.64e-05	0.0028	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Cisplatin—esophageal cancer	8.62e-05	0.00279	CcSEcCtD
Gemcitabine—Myocardial infarction—Cisplatin—esophageal cancer	8.62e-05	0.00279	CcSEcCtD
Gemcitabine—Cardiac failure—Capecitabine—esophageal cancer	8.62e-05	0.00279	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Capecitabine—esophageal cancer	8.58e-05	0.00278	CcSEcCtD
Gemcitabine—Stomatitis—Cisplatin—esophageal cancer	8.57e-05	0.00277	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Cisplatin—esophageal cancer	8.32e-05	0.00269	CcSEcCtD
Gemcitabine—Skin exfoliation—Methotrexate—esophageal cancer	8.24e-05	0.00266	CcSEcCtD
Gemcitabine—Face oedema—Capecitabine—esophageal cancer	8.12e-05	0.00263	CcSEcCtD
Gemcitabine—Blood creatinine increased—Capecitabine—esophageal cancer	7.88e-05	0.00255	CcSEcCtD
Gemcitabine—Urinary tract disorder—Cisplatin—esophageal cancer	7.8e-05	0.00252	CcSEcCtD
Gemcitabine—Liver function test abnormal—Capecitabine—esophageal cancer	7.77e-05	0.00251	CcSEcCtD
Gemcitabine—Connective tissue disorder—Cisplatin—esophageal cancer	7.76e-05	0.00251	CcSEcCtD
Gemcitabine—Urethral disorder—Cisplatin—esophageal cancer	7.74e-05	0.0025	CcSEcCtD
Gemcitabine—Pulmonary oedema—Methotrexate—esophageal cancer	7.68e-05	0.00248	CcSEcCtD
Gemcitabine—Hypokalaemia—Capecitabine—esophageal cancer	7.66e-05	0.00248	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	7.58e-05	0.00245	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	7.58e-05	0.00245	CcSEcCtD
Gemcitabine—ABCB1—epithelium—esophageal cancer	7.56e-05	0.00385	CbGeAlD
Gemcitabine—Sepsis—Methotrexate—esophageal cancer	7.49e-05	0.00242	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	7.42e-05	0.0024	CcSEcCtD
Gemcitabine—Cardiac disorder—Cisplatin—esophageal cancer	7.33e-05	0.00237	CcSEcCtD
Gemcitabine—Influenza—Capecitabine—esophageal cancer	7.27e-05	0.00235	CcSEcCtD
Gemcitabine—Bronchospasm—Capecitabine—esophageal cancer	7.15e-05	0.00231	CcSEcCtD
Gemcitabine—Immune system disorder—Cisplatin—esophageal cancer	7.13e-05	0.00231	CcSEcCtD
Gemcitabine—Mediastinal disorder—Cisplatin—esophageal cancer	7.12e-05	0.0023	CcSEcCtD
Gemcitabine—Arrhythmia—Cisplatin—esophageal cancer	7.05e-05	0.00228	CcSEcCtD
Gemcitabine—Alopecia—Cisplatin—esophageal cancer	6.98e-05	0.00226	CcSEcCtD
Gemcitabine—Hepatic failure—Methotrexate—esophageal cancer	6.97e-05	0.00225	CcSEcCtD
Gemcitabine—Pancytopenia—Capecitabine—esophageal cancer	6.9e-05	0.00223	CcSEcCtD
Gemcitabine—Erythema—Cisplatin—esophageal cancer	6.87e-05	0.00222	CcSEcCtD
Gemcitabine—Neutropenia—Capecitabine—esophageal cancer	6.8e-05	0.0022	CcSEcCtD
Gemcitabine—ABCB1—trachea—esophageal cancer	6.69e-05	0.0034	CbGeAlD
Gemcitabine—Hyperglycaemia—Capecitabine—esophageal cancer	6.56e-05	0.00212	CcSEcCtD
Gemcitabine—Pneumonia—Capecitabine—esophageal cancer	6.52e-05	0.00211	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Methotrexate—esophageal cancer	6.47e-05	0.00209	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	6.43e-05	0.00208	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Capecitabine—esophageal cancer	6.39e-05	0.00207	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Methotrexate—esophageal cancer	6.39e-05	0.00207	CcSEcCtD
Gemcitabine—Ill-defined disorder—Cisplatin—esophageal cancer	6.38e-05	0.00206	CcSEcCtD
Gemcitabine—Renal failure—Capecitabine—esophageal cancer	6.37e-05	0.00206	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Capecitabine—esophageal cancer	6.35e-05	0.00205	CcSEcCtD
Gemcitabine—Myocardial infarction—Capecitabine—esophageal cancer	6.35e-05	0.00205	CcSEcCtD
Gemcitabine—Anaemia—Cisplatin—esophageal cancer	6.35e-05	0.00205	CcSEcCtD
Gemcitabine—Stomatitis—Capecitabine—esophageal cancer	6.32e-05	0.00204	CcSEcCtD
Gemcitabine—Malaise—Cisplatin—esophageal cancer	6.2e-05	0.002	CcSEcCtD
Gemcitabine—Haematuria—Capecitabine—esophageal cancer	6.18e-05	0.002	CcSEcCtD
Gemcitabine—Leukopenia—Cisplatin—esophageal cancer	6.15e-05	0.00199	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Capecitabine—esophageal cancer	6.13e-05	0.00198	CcSEcCtD
Gemcitabine—Agranulocytosis—Capecitabine—esophageal cancer	6.05e-05	0.00196	CcSEcCtD
Gemcitabine—Lamivudine—ABCB1—esophageal cancer	5.99e-05	0.269	CrCbGaD
Gemcitabine—Myalgia—Cisplatin—esophageal cancer	5.85e-05	0.00189	CcSEcCtD
Gemcitabine—Haemoglobin—Capecitabine—esophageal cancer	5.85e-05	0.00189	CcSEcCtD
Gemcitabine—Rhinitis—Capecitabine—esophageal cancer	5.83e-05	0.00189	CcSEcCtD
Gemcitabine—Haemorrhage—Capecitabine—esophageal cancer	5.82e-05	0.00188	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	5.81e-05	0.00188	CcSEcCtD
Gemcitabine—Liver function test abnormal—Methotrexate—esophageal cancer	5.78e-05	0.00187	CcSEcCtD
Gemcitabine—Discomfort—Cisplatin—esophageal cancer	5.78e-05	0.00187	CcSEcCtD
Gemcitabine—Pharyngitis—Capecitabine—esophageal cancer	5.78e-05	0.00187	CcSEcCtD
Gemcitabine—ABCB1—digestive system—esophageal cancer	5.75e-05	0.00293	CbGeAlD
Gemcitabine—Urinary tract disorder—Capecitabine—esophageal cancer	5.75e-05	0.00186	CcSEcCtD
Gemcitabine—Oedema peripheral—Capecitabine—esophageal cancer	5.73e-05	0.00185	CcSEcCtD
Gemcitabine—Connective tissue disorder—Capecitabine—esophageal cancer	5.72e-05	0.00185	CcSEcCtD
Gemcitabine—Urethral disorder—Capecitabine—esophageal cancer	5.7e-05	0.00184	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	5.64e-05	0.00182	CcSEcCtD
Gemcitabine—Oedema—Cisplatin—esophageal cancer	5.61e-05	0.00181	CcSEcCtD
Gemcitabine—Anaphylactic shock—Cisplatin—esophageal cancer	5.61e-05	0.00181	CcSEcCtD
Gemcitabine—Infection—Cisplatin—esophageal cancer	5.57e-05	0.0018	CcSEcCtD
Gemcitabine—Erythema multiforme—Capecitabine—esophageal cancer	5.5e-05	0.00178	CcSEcCtD
Gemcitabine—Nervous system disorder—Cisplatin—esophageal cancer	5.5e-05	0.00178	CcSEcCtD
Gemcitabine—Thrombocytopenia—Cisplatin—esophageal cancer	5.49e-05	0.00178	CcSEcCtD
Gemcitabine—Skin disorder—Cisplatin—esophageal cancer	5.45e-05	0.00176	CcSEcCtD
Gemcitabine—Hyperhidrosis—Cisplatin—esophageal cancer	5.42e-05	0.00175	CcSEcCtD
Gemcitabine—Cardiac disorder—Capecitabine—esophageal cancer	5.4e-05	0.00175	CcSEcCtD
Gemcitabine—Anorexia—Cisplatin—esophageal cancer	5.35e-05	0.00173	CcSEcCtD
Gemcitabine—Angiopathy—Capecitabine—esophageal cancer	5.28e-05	0.00171	CcSEcCtD
Gemcitabine—Immune system disorder—Capecitabine—esophageal cancer	5.26e-05	0.0017	CcSEcCtD
Gemcitabine—Mediastinal disorder—Capecitabine—esophageal cancer	5.24e-05	0.0017	CcSEcCtD
Gemcitabine—Hypotension—Cisplatin—esophageal cancer	5.24e-05	0.00169	CcSEcCtD
Gemcitabine—Chills—Capecitabine—esophageal cancer	5.22e-05	0.00169	CcSEcCtD
Gemcitabine—Arrhythmia—Capecitabine—esophageal cancer	5.2e-05	0.00168	CcSEcCtD
Gemcitabine—Alopecia—Capecitabine—esophageal cancer	5.14e-05	0.00166	CcSEcCtD
Gemcitabine—Pancytopenia—Methotrexate—esophageal cancer	5.14e-05	0.00166	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	5.11e-05	0.00165	CcSEcCtD
Gemcitabine—Erythema—Capecitabine—esophageal cancer	5.07e-05	0.00164	CcSEcCtD
Gemcitabine—Neutropenia—Methotrexate—esophageal cancer	5.06e-05	0.00164	CcSEcCtD
Gemcitabine—Paraesthesia—Cisplatin—esophageal cancer	5.04e-05	0.00163	CcSEcCtD
Gemcitabine—Dyspnoea—Cisplatin—esophageal cancer	5e-05	0.00162	CcSEcCtD
Gemcitabine—Back pain—Capecitabine—esophageal cancer	4.9e-05	0.00158	CcSEcCtD
Gemcitabine—Decreased appetite—Cisplatin—esophageal cancer	4.88e-05	0.00158	CcSEcCtD
Gemcitabine—Pneumonia—Methotrexate—esophageal cancer	4.85e-05	0.00157	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Cisplatin—esophageal cancer	4.84e-05	0.00157	CcSEcCtD
Gemcitabine—ABCB1—lung—esophageal cancer	4.81e-05	0.00245	CbGeAlD
Gemcitabine—Pain—Cisplatin—esophageal cancer	4.8e-05	0.00155	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	4.78e-05	0.00155	CcSEcCtD
Gemcitabine—Renal failure—Methotrexate—esophageal cancer	4.74e-05	0.00153	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—esophageal cancer	4.7e-05	0.00152	CcSEcCtD
Gemcitabine—Ill-defined disorder—Capecitabine—esophageal cancer	4.7e-05	0.00152	CcSEcCtD
Gemcitabine—Anaemia—Capecitabine—esophageal cancer	4.68e-05	0.00151	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—esophageal cancer	4.63e-05	0.0015	CcSEcCtD
Gemcitabine—Feeling abnormal—Cisplatin—esophageal cancer	4.62e-05	0.00149	CcSEcCtD
Gemcitabine—Haematuria—Methotrexate—esophageal cancer	4.6e-05	0.00149	CcSEcCtD
Gemcitabine—Malaise—Capecitabine—esophageal cancer	4.57e-05	0.00148	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—esophageal cancer	4.56e-05	0.00148	CcSEcCtD
Gemcitabine—Leukopenia—Capecitabine—esophageal cancer	4.53e-05	0.00147	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—esophageal cancer	4.5e-05	0.00146	CcSEcCtD
Gemcitabine—Body temperature increased—Cisplatin—esophageal cancer	4.43e-05	0.00143	CcSEcCtD
Gemcitabine—Cough—Capecitabine—esophageal cancer	4.42e-05	0.00143	CcSEcCtD
Gemcitabine—Hypertension—Capecitabine—esophageal cancer	4.37e-05	0.00141	CcSEcCtD
Gemcitabine—Haemoglobin—Methotrexate—esophageal cancer	4.35e-05	0.00141	CcSEcCtD
Gemcitabine—Haemorrhage—Methotrexate—esophageal cancer	4.33e-05	0.0014	CcSEcCtD
Gemcitabine—Arthralgia—Capecitabine—esophageal cancer	4.31e-05	0.00139	CcSEcCtD
Gemcitabine—Myalgia—Capecitabine—esophageal cancer	4.31e-05	0.00139	CcSEcCtD
Gemcitabine—Chest pain—Capecitabine—esophageal cancer	4.31e-05	0.00139	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—esophageal cancer	4.3e-05	0.00139	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	4.28e-05	0.00138	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—esophageal cancer	4.28e-05	0.00138	CcSEcCtD
Gemcitabine—Discomfort—Capecitabine—esophageal cancer	4.26e-05	0.00138	CcSEcCtD
Gemcitabine—Urethral disorder—Methotrexate—esophageal cancer	4.25e-05	0.00137	CcSEcCtD
Gemcitabine—Oedema—Capecitabine—esophageal cancer	4.13e-05	0.00134	CcSEcCtD
Gemcitabine—Infection—Capecitabine—esophageal cancer	4.11e-05	0.00133	CcSEcCtD
Gemcitabine—Erythema multiforme—Methotrexate—esophageal cancer	4.1e-05	0.00132	CcSEcCtD
Gemcitabine—Nervous system disorder—Capecitabine—esophageal cancer	4.05e-05	0.00131	CcSEcCtD
Gemcitabine—Thrombocytopenia—Capecitabine—esophageal cancer	4.05e-05	0.00131	CcSEcCtD
Gemcitabine—Asthenia—Cisplatin—esophageal cancer	4.02e-05	0.0013	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—esophageal cancer	4.02e-05	0.0013	CcSEcCtD
Gemcitabine—Skin disorder—Capecitabine—esophageal cancer	4.02e-05	0.0013	CcSEcCtD
Gemcitabine—Hyperhidrosis—Capecitabine—esophageal cancer	4e-05	0.00129	CcSEcCtD
Gemcitabine—Anorexia—Capecitabine—esophageal cancer	3.94e-05	0.00127	CcSEcCtD
Gemcitabine—Angiopathy—Methotrexate—esophageal cancer	3.93e-05	0.00127	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—esophageal cancer	3.91e-05	0.00127	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—esophageal cancer	3.9e-05	0.00126	CcSEcCtD
Gemcitabine—Chills—Methotrexate—esophageal cancer	3.89e-05	0.00126	CcSEcCtD
Gemcitabine—Hypotension—Capecitabine—esophageal cancer	3.86e-05	0.00125	CcSEcCtD
Gemcitabine—Diarrhoea—Cisplatin—esophageal cancer	3.84e-05	0.00124	CcSEcCtD
Gemcitabine—Alopecia—Methotrexate—esophageal cancer	3.83e-05	0.00124	CcSEcCtD
Gemcitabine—Erythema—Methotrexate—esophageal cancer	3.77e-05	0.00122	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	3.77e-05	0.00122	CcSEcCtD
Gemcitabine—Insomnia—Capecitabine—esophageal cancer	3.74e-05	0.00121	CcSEcCtD
Gemcitabine—Paraesthesia—Capecitabine—esophageal cancer	3.71e-05	0.0012	CcSEcCtD
Gemcitabine—Dyspnoea—Capecitabine—esophageal cancer	3.69e-05	0.00119	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—esophageal cancer	3.65e-05	0.00118	CcSEcCtD
Gemcitabine—Decreased appetite—Capecitabine—esophageal cancer	3.59e-05	0.00116	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Capecitabine—esophageal cancer	3.57e-05	0.00115	CcSEcCtD
Gemcitabine—Vomiting—Cisplatin—esophageal cancer	3.57e-05	0.00115	CcSEcCtD
Gemcitabine—Fatigue—Capecitabine—esophageal cancer	3.56e-05	0.00115	CcSEcCtD
Gemcitabine—Rash—Cisplatin—esophageal cancer	3.54e-05	0.00114	CcSEcCtD
Gemcitabine—Constipation—Capecitabine—esophageal cancer	3.54e-05	0.00114	CcSEcCtD
Gemcitabine—Pain—Capecitabine—esophageal cancer	3.54e-05	0.00114	CcSEcCtD
Gemcitabine—Dermatitis—Cisplatin—esophageal cancer	3.53e-05	0.00114	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—esophageal cancer	3.5e-05	0.00113	CcSEcCtD
Gemcitabine—Anaemia—Methotrexate—esophageal cancer	3.49e-05	0.00113	CcSEcCtD
Gemcitabine—Feeling abnormal—Capecitabine—esophageal cancer	3.41e-05	0.0011	CcSEcCtD
Gemcitabine—Malaise—Methotrexate—esophageal cancer	3.4e-05	0.0011	CcSEcCtD
Gemcitabine—Leukopenia—Methotrexate—esophageal cancer	3.38e-05	0.00109	CcSEcCtD
Gemcitabine—Nausea—Cisplatin—esophageal cancer	3.33e-05	0.00108	CcSEcCtD
Gemcitabine—Cough—Methotrexate—esophageal cancer	3.29e-05	0.00106	CcSEcCtD
Gemcitabine—ABCB1—lymph node—esophageal cancer	3.29e-05	0.00167	CbGeAlD
Gemcitabine—Body temperature increased—Capecitabine—esophageal cancer	3.27e-05	0.00106	CcSEcCtD
Gemcitabine—Myalgia—Methotrexate—esophageal cancer	3.21e-05	0.00104	CcSEcCtD
Gemcitabine—Arthralgia—Methotrexate—esophageal cancer	3.21e-05	0.00104	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—esophageal cancer	3.21e-05	0.00104	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	3.19e-05	0.00103	CcSEcCtD
Gemcitabine—Discomfort—Methotrexate—esophageal cancer	3.17e-05	0.00103	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methotrexate—esophageal cancer	3.08e-05	0.000995	CcSEcCtD
Gemcitabine—Infection—Methotrexate—esophageal cancer	3.06e-05	0.000989	CcSEcCtD
Gemcitabine—Nervous system disorder—Methotrexate—esophageal cancer	3.02e-05	0.000976	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—esophageal cancer	3.01e-05	0.000974	CcSEcCtD
Gemcitabine—Skin disorder—Methotrexate—esophageal cancer	2.99e-05	0.000967	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methotrexate—esophageal cancer	2.98e-05	0.000962	CcSEcCtD
Gemcitabine—Asthenia—Capecitabine—esophageal cancer	2.97e-05	0.000959	CcSEcCtD
Gemcitabine—Anorexia—Methotrexate—esophageal cancer	2.93e-05	0.000949	CcSEcCtD
Gemcitabine—Pruritus—Capecitabine—esophageal cancer	2.93e-05	0.000946	CcSEcCtD
Gemcitabine—Hypotension—Methotrexate—esophageal cancer	2.88e-05	0.00093	CcSEcCtD
Gemcitabine—Diarrhoea—Capecitabine—esophageal cancer	2.83e-05	0.000915	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	2.8e-05	0.000907	CcSEcCtD
Gemcitabine—Insomnia—Methotrexate—esophageal cancer	2.78e-05	0.0009	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—esophageal cancer	2.76e-05	0.000894	CcSEcCtD
Gemcitabine—Dyspnoea—Methotrexate—esophageal cancer	2.74e-05	0.000887	CcSEcCtD
Gemcitabine—Somnolence—Methotrexate—esophageal cancer	2.74e-05	0.000885	CcSEcCtD
Gemcitabine—Decreased appetite—Methotrexate—esophageal cancer	2.68e-05	0.000865	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—esophageal cancer	2.66e-05	0.000859	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—esophageal cancer	2.65e-05	0.000858	CcSEcCtD
Gemcitabine—Pain—Methotrexate—esophageal cancer	2.63e-05	0.000851	CcSEcCtD
Gemcitabine—Vomiting—Capecitabine—esophageal cancer	2.63e-05	0.00085	CcSEcCtD
Gemcitabine—Rash—Capecitabine—esophageal cancer	2.61e-05	0.000843	CcSEcCtD
Gemcitabine—Dermatitis—Capecitabine—esophageal cancer	2.6e-05	0.000842	CcSEcCtD
Gemcitabine—Headache—Capecitabine—esophageal cancer	2.59e-05	0.000837	CcSEcCtD
Gemcitabine—Feeling abnormal—Methotrexate—esophageal cancer	2.54e-05	0.00082	CcSEcCtD
Gemcitabine—Nausea—Capecitabine—esophageal cancer	2.46e-05	0.000794	CcSEcCtD
Gemcitabine—Body temperature increased—Methotrexate—esophageal cancer	2.43e-05	0.000787	CcSEcCtD
Gemcitabine—Asthenia—Methotrexate—esophageal cancer	2.21e-05	0.000714	CcSEcCtD
Gemcitabine—Pruritus—Methotrexate—esophageal cancer	2.18e-05	0.000704	CcSEcCtD
Gemcitabine—Diarrhoea—Methotrexate—esophageal cancer	2.11e-05	0.000681	CcSEcCtD
Gemcitabine—Vomiting—Methotrexate—esophageal cancer	1.96e-05	0.000633	CcSEcCtD
Gemcitabine—Rash—Methotrexate—esophageal cancer	1.94e-05	0.000627	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—esophageal cancer	1.94e-05	0.000627	CcSEcCtD
Gemcitabine—Headache—Methotrexate—esophageal cancer	1.93e-05	0.000623	CcSEcCtD
Gemcitabine—Nausea—Methotrexate—esophageal cancer	1.83e-05	0.000591	CcSEcCtD
Gemcitabine—RRM1—Metabolism—ENO1—esophageal cancer	1.09e-05	0.000342	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS1—esophageal cancer	1.09e-05	0.000342	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CREBBP—esophageal cancer	1.09e-05	0.000342	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—RB1—esophageal cancer	1.09e-05	0.000342	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—RB1—esophageal cancer	1.09e-05	0.000339	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GNG7—esophageal cancer	1.08e-05	0.000337	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PSME2—esophageal cancer	1.08e-05	0.000337	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PSME1—esophageal cancer	1.08e-05	0.000337	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	1.07e-05	0.000335	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GNG7—esophageal cancer	1.07e-05	0.000335	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PLCE1—esophageal cancer	1.07e-05	0.000335	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ADH7—esophageal cancer	1.07e-05	0.000335	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GAPDH—esophageal cancer	1.07e-05	0.000334	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.06e-05	0.000332	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CRABP1—esophageal cancer	1.06e-05	0.000331	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.05e-05	0.00033	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—HMOX1—esophageal cancer	1.05e-05	0.000329	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—RB1—esophageal cancer	1.05e-05	0.000328	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.01e-05	0.000316	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ABCB1—esophageal cancer	1.01e-05	0.000316	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALDH2—esophageal cancer	1.01e-05	0.000316	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GNG7—esophageal cancer	1.01e-05	0.000315	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALDH2—esophageal cancer	1e-05	0.000314	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—RB1—esophageal cancer	9.99e-06	0.000312	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.98e-06	0.000312	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—NOS3—esophageal cancer	9.78e-06	0.000306	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—RB1—esophageal cancer	9.76e-06	0.000305	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—RB1—esophageal cancer	9.7e-06	0.000304	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—EP300—esophageal cancer	9.7e-06	0.000303	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTT1—esophageal cancer	9.6e-06	0.0003	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	9.6e-06	0.0003	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	9.59e-06	0.0003	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTT1—esophageal cancer	9.54e-06	0.000298	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	9.54e-06	0.000298	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP2A6—esophageal cancer	9.49e-06	0.000297	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP2A6—esophageal cancer	9.43e-06	0.000295	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALDH2—esophageal cancer	9.43e-06	0.000295	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ADH1B—esophageal cancer	9.39e-06	0.000294	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—RB1—esophageal cancer	9.37e-06	0.000293	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP8—esophageal cancer	9.32e-06	0.000291	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP1B1—esophageal cancer	9.29e-06	0.000291	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	9.21e-06	0.000288	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	9.19e-06	0.000287	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS1—esophageal cancer	9e-06	0.000281	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ENO1—esophageal cancer	9e-06	0.000281	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	8.99e-06	0.000281	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TYMP—esophageal cancer	8.97e-06	0.000281	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTT1—esophageal cancer	8.97e-06	0.000281	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS1—esophageal cancer	8.94e-06	0.00028	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ENO1—esophageal cancer	8.94e-06	0.00028	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—esophageal cancer	8.94e-06	0.00028	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP2A6—esophageal cancer	8.87e-06	0.000277	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PSME2—esophageal cancer	8.87e-06	0.000277	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PSME1—esophageal cancer	8.87e-06	0.000277	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PSME2—esophageal cancer	8.81e-06	0.000276	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PSME1—esophageal cancer	8.81e-06	0.000276	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	8.81e-06	0.000275	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	8.77e-06	0.000274	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP19A1—esophageal cancer	8.73e-06	0.000273	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP26A1—esophageal cancer	8.73e-06	0.000273	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	8.61e-06	0.000269	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—esophageal cancer	8.58e-06	0.000268	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—esophageal cancer	8.53e-06	0.000267	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALOX15—esophageal cancer	8.51e-06	0.000266	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ENO1—esophageal cancer	8.41e-06	0.000263	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS1—esophageal cancer	8.41e-06	0.000263	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	8.35e-06	0.000261	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	8.3e-06	0.000259	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PSME1—esophageal cancer	8.29e-06	0.000259	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PSME2—esophageal cancer	8.29e-06	0.000259	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—esophageal cancer	8.24e-06	0.000258	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTO1—esophageal cancer	8.11e-06	0.000254	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TPI1—esophageal cancer	8.11e-06	0.000254	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—esophageal cancer	8.11e-06	0.000254	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	8.07e-06	0.000252	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—esophageal cancer	8.06e-06	0.000252	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—HMOX1—esophageal cancer	7.97e-06	0.000249	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	7.85e-06	0.000245	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	7.8e-06	0.000244	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.8e-06	0.000244	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	7.8e-06	0.000244	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—esophageal cancer	7.78e-06	0.000243	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALDOB—esophageal cancer	7.78e-06	0.000243	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP1B1—esophageal cancer	7.65e-06	0.000239	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ABCB1—esophageal cancer	7.65e-06	0.000239	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP1B1—esophageal cancer	7.6e-06	0.000238	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	7.55e-06	0.000236	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	7.53e-06	0.000236	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GAPDH—esophageal cancer	7.49e-06	0.000234	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	7.47e-06	0.000234	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—RB1—esophageal cancer	7.47e-06	0.000234	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—EP300—esophageal cancer	7.47e-06	0.000233	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—EP300—esophageal cancer	7.44e-06	0.000233	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CRABP1—esophageal cancer	7.42e-06	0.000232	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—EP300—esophageal cancer	7.42e-06	0.000232	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	7.39e-06	0.000231	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	7.3e-06	0.000228	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—esophageal cancer	7.25e-06	0.000227	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	7.23e-06	0.000226	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—esophageal cancer	7.21e-06	0.000225	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP19A1—esophageal cancer	7.19e-06	0.000225	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—EP300—esophageal cancer	7.17e-06	0.000224	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RB1—esophageal cancer	7.16e-06	0.000224	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP19A1—esophageal cancer	7.15e-06	0.000224	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1B1—esophageal cancer	7.15e-06	0.000224	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	7.07e-06	0.000221	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GNG7—esophageal cancer	7.06e-06	0.000221	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	7.05e-06	0.000221	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1A—esophageal cancer	7.02e-06	0.000219	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1A—esophageal cancer	6.97e-06	0.000218	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—esophageal cancer	6.96e-06	0.000218	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—esophageal cancer	6.94e-06	0.000217	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	6.85e-06	0.000214	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.76e-06	0.000212	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.76e-06	0.000212	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CREBBP—esophageal cancer	6.75e-06	0.000211	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1A—esophageal cancer	6.73e-06	0.000211	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP19A1—esophageal cancer	6.72e-06	0.00021	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—RB1—esophageal cancer	6.68e-06	0.000209	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—EP300—esophageal cancer	6.67e-06	0.000209	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—EP300—esophageal cancer	6.63e-06	0.000208	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALDH2—esophageal cancer	6.62e-06	0.000207	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	6.57e-06	0.000205	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—HMOX1—esophageal cancer	6.56e-06	0.000205	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—HMOX1—esophageal cancer	6.52e-06	0.000204	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—esophageal cancer	6.51e-06	0.000203	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	6.48e-06	0.000203	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—esophageal cancer	6.47e-06	0.000202	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—EP300—esophageal cancer	6.41e-06	0.0002	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RB1—esophageal cancer	6.4e-06	0.0002	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ABCB1—esophageal cancer	6.3e-06	0.000197	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTT1—esophageal cancer	6.29e-06	0.000197	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	6.29e-06	0.000197	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ABCB1—esophageal cancer	6.26e-06	0.000196	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—esophageal cancer	6.24e-06	0.000195	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP2A6—esophageal cancer	6.22e-06	0.000195	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—HMOX1—esophageal cancer	6.13e-06	0.000192	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NOS3—esophageal cancer	6.04e-06	0.000189	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ENO1—esophageal cancer	5.9e-06	0.000184	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS1—esophageal cancer	5.9e-06	0.000184	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ABCB1—esophageal cancer	5.89e-06	0.000184	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—esophageal cancer	5.87e-06	0.000184	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—esophageal cancer	5.82e-06	0.000182	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PSME1—esophageal cancer	5.81e-06	0.000182	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PSME2—esophageal cancer	5.81e-06	0.000182	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—esophageal cancer	5.78e-06	0.000181	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—esophageal cancer	5.62e-06	0.000176	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—esophageal cancer	5.58e-06	0.000175	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—esophageal cancer	5.55e-06	0.000173	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—esophageal cancer	5.52e-06	0.000173	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—esophageal cancer	5.5e-06	0.000172	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	5.37e-06	0.000168	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—esophageal cancer	5.31e-06	0.000166	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	5.14e-06	0.000161	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	5.13e-06	0.00016	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CREBBP—esophageal cancer	5.11e-06	0.00016	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—EP300—esophageal cancer	5.11e-06	0.00016	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1B1—esophageal cancer	5.01e-06	0.000157	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—esophageal cancer	4.96e-06	0.000155	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—EP300—esophageal cancer	4.89e-06	0.000153	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1A—esophageal cancer	4.8e-06	0.00015	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—esophageal cancer	4.78e-06	0.000149	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—esophageal cancer	4.75e-06	0.000149	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—esophageal cancer	4.75e-06	0.000148	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP19A1—esophageal cancer	4.71e-06	0.000147	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.65e-06	0.000145	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	4.6e-06	0.000144	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1A—esophageal cancer	4.6e-06	0.000144	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—EP300—esophageal cancer	4.6e-06	0.000144	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—esophageal cancer	4.59e-06	0.000143	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NOS3—esophageal cancer	4.58e-06	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	4.58e-06	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BLVRB—esophageal cancer	4.57e-06	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC52A3—esophageal cancer	4.57e-06	0.000143	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—EP300—esophageal cancer	4.57e-06	0.000143	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—esophageal cancer	4.45e-06	0.000139	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—EP300—esophageal cancer	4.37e-06	0.000137	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—HMOX1—esophageal cancer	4.3e-06	0.000135	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—esophageal cancer	4.26e-06	0.000133	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CREBBP—esophageal cancer	4.21e-06	0.000132	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—esophageal cancer	4.19e-06	0.000131	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CREBBP—esophageal cancer	4.19e-06	0.000131	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCB1—esophageal cancer	4.13e-06	0.000129	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—esophageal cancer	3.98e-06	0.000124	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.95e-06	0.000123	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CREBBP—esophageal cancer	3.93e-06	0.000123	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CA1—esophageal cancer	3.89e-06	0.000122	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.89e-06	0.000122	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.83e-06	0.00012	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—esophageal cancer	3.81e-06	0.000119	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NOS3—esophageal cancer	3.77e-06	0.000118	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3.75e-06	0.000117	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NOS3—esophageal cancer	3.75e-06	0.000117	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CA2—esophageal cancer	3.55e-06	0.000111	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NOS3—esophageal cancer	3.52e-06	0.00011	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—EP300—esophageal cancer	3.48e-06	0.000109	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—esophageal cancer	3.45e-06	0.000108	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—esophageal cancer	3.43e-06	0.000107	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—esophageal cancer	3.4e-06	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.39e-06	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ADH7—esophageal cancer	3.3e-06	0.000103	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLCE1—esophageal cancer	3.3e-06	0.000103	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.28e-06	0.000102	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—esophageal cancer	3.27e-06	0.000102	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—esophageal cancer	3.22e-06	0.000101	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—esophageal cancer	3.13e-06	9.79e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.12e-06	9.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ADH1B—esophageal cancer	2.9e-06	9.06e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—EP300—esophageal cancer	2.87e-06	8.97e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—EP300—esophageal cancer	2.85e-06	8.91e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.83e-06	8.86e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TYMP—esophageal cancer	2.77e-06	8.66e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CREBBP—esophageal cancer	2.76e-06	8.63e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.72e-06	8.5e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.69e-06	8.42e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—EP300—esophageal cancer	2.68e-06	8.38e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.66e-06	8.31e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALOX15—esophageal cancer	2.62e-06	8.21e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—esophageal cancer	2.58e-06	8.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTO1—esophageal cancer	2.5e-06	7.83e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TPI1—esophageal cancer	2.5e-06	7.83e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NOS3—esophageal cancer	2.47e-06	7.73e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALDOB—esophageal cancer	2.4e-06	7.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GAPDH—esophageal cancer	2.31e-06	7.23e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.31e-06	7.21e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CRABP1—esophageal cancer	2.29e-06	7.16e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—esophageal cancer	2.26e-06	7.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.23e-06	6.98e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNG7—esophageal cancer	2.18e-06	6.81e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—esophageal cancer	2.12e-06	6.63e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—esophageal cancer	2.11e-06	6.59e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALDH2—esophageal cancer	2.04e-06	6.38e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—esophageal cancer	1.98e-06	6.2e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTT1—esophageal cancer	1.94e-06	6.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.92e-06	6e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—EP300—esophageal cancer	1.88e-06	5.88e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS1—esophageal cancer	1.82e-06	5.69e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ENO1—esophageal cancer	1.82e-06	5.69e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.82e-06	5.69e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PSME1—esophageal cancer	1.79e-06	5.61e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PSME2—esophageal cancer	1.79e-06	5.61e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.55e-06	4.84e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.45e-06	4.55e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—esophageal cancer	1.39e-06	4.35e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HMOX1—esophageal cancer	1.33e-06	4.15e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CREBBP—esophageal cancer	8.51e-07	2.66e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NOS3—esophageal cancer	7.62e-07	2.38e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—esophageal cancer	6.97e-07	2.18e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—EP300—esophageal cancer	5.8e-07	1.81e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—esophageal cancer	4.29e-07	1.34e-05	CbGpPWpGaD
